Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.

Emerging issues related to COVID-19 vaccination in patients with cancer / K.S. Saini, D. Martins-Branco, M. Tagliamento, L. Vidal, N. Singh, K. Punie, M.L. Saini, I. Chico, G. Curigliano, E. de Azambuja, M. Lambertini. - In: ONCOLOGY AND THERAPY. - ISSN 2366-1070. - (2021). [Epub ahead of print] [10.1007/s40487-021-00157-1]

Emerging issues related to COVID-19 vaccination in patients with cancer

G. Curigliano
Conceptualization
;
2021

Abstract

Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
Cancer; COVID-19; Efficacy; mRNA; SARS-CoV-2; Toxicity; Vaccine; Viral vector
Settore MED/06 - Oncologia Medica
2021
16-giu-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Saini and CURIGLIANO 2021.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 312.96 kB
Formato Adobe PDF
312.96 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/853159
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact